News

Community Health sells four Arkansas hospitals for $110M, extending its asset-sale aimed at boosting liquidity, cutting debt and sharpening its healthcare portfolio.

These large-cap companies could be poised to join the dividend club, based on cash holdings and free-cash flow yield, according to Morgan Stanley.

We just covered the 10 Best Stocks to Buy Right Now According to AI and Centene Corporation (NYSE:CNC) ranks 8th on this list. Centene Corporation (NYSE:CNC) is a major healthcare enterprise that operates as a leading intermediary for both government-sponsored and commercial managed care programs. The company primarily focuses on providing health insurance coverage through […]

UNH plans to eliminate nearly two-thirds of pediatric prior authorizations by year-end, aiming to speed care access and reduce provider paperwork.

PBI, CNC and MPC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 1st, 2026.

The oil price future may not be like anything we have seen.

Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Companies in The News Are: DY, BBWI, PDD, CNC

PBI, CNC and MPC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 28, 2026.

MOH's premium valuation reflects confidence in growth, acquisitions and cash strength, even as elevated medical costs pressure margins.

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.61%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.76%. June E-mini S&P futures (ESM26 ) rose +0.61%, and June E-mini Nasdaq futures...

The S&P 500 Index ($SPX ) (SPY ) today is up +0.81%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.74%. June E-mini S&P futures (ESM26 ) are up +0.77%, and June E-mini Nasdaq futures...

CNC, SANM and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 26, 2026.

Earlier this week, BofA Securities issued a report suggesting Centene’s earnings per share could be several times higher by 2029, primarily driven by improved Medicaid margins and a rebound in managed care profitability after recent pressure. The report also argues that Centene’s 2026 earnings guidance reflects only a fraction of its perceived potential, implying current expectations may underappreciate the scope for Medicaid margin recovery based on historical patterns. We’ll now examine...

Centene (CNC) and Molina Healthcare (MOH) have "compelling" EPS upside potential and could see their

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.

The S&P 500 Index ($SPX ) (SPY ) today is up +0.27%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.55%. June E-mini S&P futures (ESM26 ) are up +0.26%, and June E-mini Nasdaq futures...

Cigna downgraded, Humana upgraded: Wall Street's top analyst calls

Investing.com -- Analysts turned more bullish on the managed care sector, upgrading shares of Humana, Centene, and Elevance Health to “Buy,” while downgrading The Cigna Group to “Hold” on valuation concerns.

Pre-Market Stock Futures: Futures are trading higher on the heels of the third straight day of stock declines, and there is growing apprehension that yields will go even higher and that inflation may as well. All of the major indices finished Tuesday lower, and with Q1 earnings all but over and the incoming economic data ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: BJ’s Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and More

June Nasdaq 100 E-Mini futures (NQM26) are trending up +0.69% this morning as sentiment improved after Treasury yields retreated from multiyear highs, with attention now turning to an earnings report from chip giant Nvidia.

UNH is under the spotlight after Berkshire Hathaway's 13F reveals it exited its entire stake, sparking surprise selling and fresh scrutiny on headwinds.

CYH streamlines operations through asset sales, but weaker cash generation temper optimism.

CI trades below the industry's forward P/E as Evernorth's growth, earnings beats and shareholder returns support its long-term outlook.

The topics and banter at this year’s Sohn Investment Conference offered a glimpse at what is on the minds of top fund managers.

Centene (CNC) is back in focus after reporting first quarter results showing higher revenue, net income, and earnings per share compared with a year earlier, along with raised 2026 revenue and GAAP diluted EPS guidance. See our latest analysis for Centene. The strong first quarter and raised 2026 guidance have coincided with a sharp shift in sentiment. A 59.01% 1 month share price return and a modest 0.58% 1 year total shareholder return suggest that momentum has recently picked up after a...

Centene Corporation (NYSE:CNC) is one of the best healthcare stocks to buy for the long term. TD Cowen lifted the price target on Centene Corporation (NYSE:CNC) to $48 from $38 on May 4, reaffirming a Hold rating on the shares. The firm updated its model on the stock after its fiscal Q1 financial results, stating […]

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.16%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.87%. June E-mini S&P futures (ESM26 ) fell -0.16%, and June E-mini Nasdaq futures...

Greenlight Capital's David Einhorn pitched two investment ideas Tuesday at the Sohn Investment Conference that he says are undervalued beneficiaries of the artificial-intelligence boom: Centene: The managed-care company can use AI to speed up manually repetitive processes such as claims processing, Einhorn said.

UNH's Optum Rx unveils a transparent, fee-based PBM model, ditching spread pricing and adding real-time cost tools as regulators push for lower drug pricing.